Clinical trial
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
NCT01206647 is registered in ClinicalTrials.gov with ikfe-CRO GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
- Lead sponsor
- ikfe-CRO GmbH
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 28, 2010
- Completion date
- February 28, 2011
- Enrollment
- 120 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.